Ikena Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Ikena Oncology and buy or sell other stocks, ETFs, and their options commission-free!About IKNA
ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life.
CEOKristin Yarema, PhD
CEOKristin Yarema, PhD
Employees10
Employees10
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded
Founded
Employees10
Employees10
IKNA Key Statistics
Market cap15.23M
Market cap15.23M
Price-Earnings ratio-0.84
Price-Earnings ratio-0.84
Dividend yield—
Dividend yield—
Average volume67.17K
Average volume67.17K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.28
52 Week high$23.28
52 Week low$6.19
52 Week low$6.19
Stock Snapshot
The current Ikena Oncology(IKNA) stock price is $1.43, with a market capitalization of 15.23M. The stock trades at a price-to-earnings (P/E) ratio of -0.84.
Ikena Oncology(IKNA) stock opened on 2025-12-05 at —. The price climbed to — and dipped to —.
Ikena Oncology(IKNA) shares are trading with a volume of 0, against a daily average of 67.17K.
During the past year, Ikena Oncology(IKNA) stock moved between $6.19 at its lowest and $23.28 at its peak.
During the past year, Ikena Oncology(IKNA) stock moved between $6.19 at its lowest and $23.28 at its peak.
People also own
Based on the portfolios of people who own IKNA. This list is generated using Robinhood data, and it’s not a recommendation.